« Previous
Next »
Titles
- Compounded drug products that are essentially copies of approved drug products under Section 503B of the Federal Food, Drug, and Cosmetic Act1
- Coverage and care pathways for people with HIV: a new baseline1
- Coverage options for Mississippians after implementation of the ACA1
- Creating a culture for innovation and risk taking in transformative times1
- Creating seamless coverage transitions between Medicaid and the exchanges1